Large BTS was an independent negative predictor of OS in patients with melanoma who received PD-1 inhibitor monotherapy (26) and of PFS and OS in patients with NSCLC who received PD-1/PD-L1 inhibitors monotherapy (24). This evidence concerns the gene CD274 and non-small cell lung carcinoma.